Hydroxyl radical formation following methamphetamine administration to rats

Pharmacology and Toxicology

Volumn 85, Issue 5, 1999, Pages 133-137

  Kita, Taizo ^a   Takahashi, Masahiro ^a   Kubo, Kaoru ^a   Wagner, George C ^b   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOSE RESPONSE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE;

ANIMALIA;

EID: 0032887804     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb00080.x     Document Type: Article

References (26)

1. Albers, D. S. & P. K. Sonsalla: Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Therap. 1995, 275, 1104-1114.
2. Axt, K. J. & M. E. Molliver: Immunocytochcmical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 1991, 9, 302-313.
3. Bowyer, J. F., D. L. Davies, L. Schmued, H. W. Broening, G. D. Newport, W. Slikker Jr. & R. R. Holson; Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Therap. 1994, 268, 1571-1580.
4. Cadet, J. L., P. Sheng, S. Ali, R. Rothman, E. Carlson & C. Epstein: Attenuation of methamphetamine-induced neurotoxicity in copper/zinc Superoxide dismutase transgenic mice. J. Neurochem. 1994, 62, 380-383.
5. Cappon, G. D., H. W. Broening, C. Pu, L. Morford & C. V. Vorhees: α-phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 1996, 24, 173-181.
6. Cohen, G. & R. E. Heikkila: The generation of hydrogen peroxide, Superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 1974, 249, 2447-2452.
7. Commins, D. L., K. J. Axt, G. Vosmer & L. S. Seiden: 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain. Brain Res. 1987, 403, 7-14.
8. De Vito, M. J. & G. C. Wagner: Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacol. 1989, 28, 1145-1150.
9. Fleckenstein, A. E., D. G. Wilkins, J. W. Gibb & G. R. Hanson: Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Therap. 1997, 283, 281-285.
10. Floyd, R. A., J. J. Watson & P. K. Wong: Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Meth. 1984, 10, 221-235.
11. Fumagalli, F., R. R. Gainetdinov, K. J. Valenzano & M. G. Caron: Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 1998, 18, 4861-4869.
12. Gerlach, M. & P. Riederer: Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Trans. 1996, 103, 987-1041.
13. Giovanni, A., L. P. Liang, T. G. Hastings & M. J. Zigmond: Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine, J. Neurochem. 1995, 64, 1819-1825.
14. Hirata, H., B. Ladenheim, R. B. Rothman, C. Epstein & J. L. Cadet: Methamphetamine-induced serotonin neurotoxicity is mediated by Superoxide radicals. Brain Res. 1995, 677, 345-347.
15. Hotchkiss, A. J. & J. W. Gibb: Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Therap. 1980, 214, 257-262.
16. Karoum, F., S. J. Chrapusta, M. F. Egan & R. J. Wyatt: Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. J. Neurochem. 1993, 61, 1369-1375.
17. Kita, T., G. C. Wagner, M. A. Philbert, L. A. King & H. E. Lowndes: Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion. Mol. Chem. Neuropathol. 1995, 24, 31-41.
18. Kita, T., M. A. Philbert, G. C. Wagner, J. Huang & H. E. Lowndes: Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes. Pharmacology. Toxicology. 1998, 83, 36-39.
19. Monks, T. J., R. P. Hanzlik, G. M. Cohen, D. Ross & D. G. Graham: Contemporary issues in toxicology: quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 1992, 112, 2-16.
20. Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Academic Press, New York, 1986
21. Ricaurte, G. A., C. R. Schuster & L. S. Seiden: Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 1980, 193, 153-163.
22. Rollema, H., J. B. De Vries, B. H. C. Westerink, F. M. S. Van Putten & A.S. Horn: Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine, and MPTP. Eur. J. Pharmacol. 1986, 132, 65-69.
23. Seiden, L. S. & G. Vosmer Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methamphetamine. Pharmacol. Biochem. Behav. 1984, 21, 29-31.
24. Wagner, G. C., R. M. Carrelli & M. F. Jarvis: Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Comm. Chem. Path. Pharmacol. 1985, 47, 221-228.
25. Wilde, G. J., A. K. Pringle, P. Wright & F. Iannotti: Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro. J. Neurochem. 1997, 69, 883-886.
26. Yamamoto, T., S. Yuki, T. Watanabe, M. Mitsuka, K. I. Saito & K. Kogure: Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res. 1997, 762, 240-242.